Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Edmund Dunn currently holds 22,554 shares of Monte Rosa Therapeutics, Inc. (GLUE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Edmund Dunn has been a net seller of GLUE stock. They have purchased $0 and sold $13.5K worth of shares.
Edmund Dunn's most recent insider trade was on Mar 4, 2026, when they sold 139 shares at $17.96 per share.
Edmund Dunn serves as Executive at Monte Rosa Therapeutics, Inc. (GLUE). They have executed 5 insider transactions totaling $13.5K over their tenure at the company.
Edmund Dunn holds the position of Executive at Monte Rosa Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Edmund Dunn has shown a selling trading pattern, with $0 in total purchases and $13.5K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Edmund Dunn was on Jul 5, 2024, when they sold $6.2K worth of GLUE shares. This transaction involved 1,610 shares at $3.83 per share.
Edmund Dunn currently owns 22,554 shares of Monte Rosa Therapeutics, Inc. (GLUE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Edmund Dunn's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Edmund Dunn has 5 Form 4 filings on record as an insider at Monte Rosa Therapeutics, Inc..
Set alerts for Edmund Dunn and 40,000+ other insiders.